Science News

BOCA RATON, Fla.--(BUSINESS WIRE)--LGM Pharma’s additional investments in its Texas and Colorado sites will support growing demand for U.S.-based end-to-end pharma manufacturing....

COLORADO SPRINGS, Colo.--(BUSINESS WIRE)--Sanborn, in collaboration with the M-NCPPC and Prince George's County, Maryland, has been recognized with a Geospatial Excellence Award from MAPPS....

ST. LOUIS--(BUSINESS WIRE)--C2N Diagnostics, LLC (“C2N”), a specialty diagnostics company with a vision to bring Clarity Through Innovation®, highlighted the first use of its eMTBR-tau243 plasma assay in a Phase 3 dataset (Evoke/Evoke+), reflecting ongoing interest in tau-related signals within Alzheimer’s disease research. The data were presented at the AD/PD™ 2026 Alzheimer's & Parkinson's Diseases Conference during the Evoke/Evoke+ Trial Symposium, which focused on Evoke and Evoke+ cereb...

EMERYVILLE, Calif.--(BUSINESS WIRE)--Fauna Bio, a biotechnology company pioneering the use of extreme mammal biology and comparative genomics to discover novel therapeutic targets, today announced the designation of a target under its strategic obesity discovery collaboration with Eli Lilly and Company (Lilly), initiated in December, 2023. The designated target, identified using Fauna Bio’s proprietary Convergence™ AI platform, represents a potential first-in-class approach to treating obesity...

PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Report Results for First Quarter 2026 on April 30, 2026...

NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced positive topline results from the Phase 3 TALAPRO-3 study of TALZENNA® (talazoparib), an oral poly ADP-ribose polymerase (PARP) inhibitor, in combination with XTANDI® (enzalutamide), an androgen receptor pathway inhibitor (ARPI), in people with homologous recombination repair (HRR) gene-mutated metastatic castration-sensitive prostate cancer (mCSPC), also known as metastatic hormone-sensitive prostate cancer (mHSPC). The study m...

LAVAL, Quebec--(BUSINESS WIRE)--BIOQuébec, the association representing the life sciences and health technologies (LSHT) industry, notes that the government is exercising caution by maintaining its direction for these strategic sectors. The 2026–2027 budget is in line with the priorities established by the Quebec Life Sciences Strategy as well as the Quebec Research and Innovation Investment Strategy, thereby confirming the central role of these sectors in Quebec’s economic development. The gov...

BOSTON & STAFFORDSHIRE, England--(BUSINESS WIRE)--Instem announces a 5-year extension of its Research Collaboration Agreement (RCA) with the U.S. Food and Drug Administration (FDA)....

ZURICH--(BUSINESS WIRE)--AL-S Pharma AG, a clinical-stage biotechnology company discovering and developing human antibodies that target misfolded proteins implicated in amyotrophic lateral sclerosis (ALS), today announced the presentation of new clinical data from the global Phase 2 clinical trial (AP-101-02) evaluating the company’s lead program, AP-101, in patients with ALS. AP-101 is an investigational human-derived antibody directed against misfolded superoxide dismutase 1 (SOD1). AP-101 is...

LOS ANGELES--(BUSINESS WIRE)--AltaSea at the Port of Los Angeles, the world’s leading tech hub for the blue economy, today announced the appointment of businessman and philanthropist Jon Sutton Day to its Board of Trustees, effective March 31. A lifelong Angeleno, Day currently serves on the Board of Directors of the W.M. Keck Foundation, one of the nation’s largest philanthropic foundations supporting medical research, science and engineering, and educational programs. He is on the Foundation’...